Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
29.01
+2.16 (8.04%)
At close: Dec 20, 2024, 4:00 PM
29.03
+0.02 (0.07%)
After-hours: Dec 20, 2024, 5:35 PM EST
Beam Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$47.67
Upside
+64.32%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +175.77% | Dec 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +175.77% | Nov 7, 2024 |
RBC Capital | RBC Capital | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | -17.27% | Nov 6, 2024 |
Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 → $39 | Hold → Buy | Upgrades | $27 → $39 | +34.44% | Nov 6, 2024 |
Scotiabank | Scotiabank | Hold Initiates $24 | Hold | Initiates | $24 | -17.27% | Oct 16, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $27 | Hold | Reiterates | $27 | -6.93% | Sep 19, 2024 |
Jones Trading | Jones Trading | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 17, 2024 |
Stifel | Stifel | Strong Buy Maintains $66 → $69 | Strong Buy | Maintains | $66 → $69 | +137.85% | Sep 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +175.77% | Aug 22, 2024 |
JP Morgan | JP Morgan | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +65.46% | Aug 7, 2024 |
Barclays | Barclays | Hold Maintains $33 → $31 | Hold | Maintains | $33 → $31 | +6.86% | Aug 7, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $27 | Hold | Reiterates | $27 | -6.93% | Aug 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +175.77% | Jul 23, 2024 |
Barclays | Barclays | Hold Maintains $42 → $33 | Hold | Maintains | $42 → $33 | +13.75% | May 8, 2024 |
Wedbush | Wedbush | Buy Reiterates $57 | Buy | Reiterates | $57 | +96.48% | Apr 23, 2024 |
BMO Capital | BMO Capital | Buy Maintains $57 | Buy | Maintains | $57 | +96.48% | Mar 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.